Arginine vasotocin as a pineal hormone

Area of Science:

• Neuroendocrinology
• Chronobiology
• Molecular Endocrinology

Background:

• The pineal gland produces arginine vasotocin (AVT), a nonapeptide hormone.
• AVT is released into cerebrospinal fluid (CSF) and secondarily enters the bloodstream.
• AVT exhibits a diurnal rhythm, suggesting nocturnal release into the CSF.

Purpose of the Study:

• To elucidate the synthesis, release, and mechanism of action of AVT.
• To investigate the role of AVT in endocrine regulation and sleep induction.
• To identify the receptors and primary site of action for AVT in the mammalian brain.

Main Methods:

• The study likely involved analysis of pineal gland and CSF samples.
• Investigated diurnal rhythms of AVT.
• Examined AVT's effects on neurotransmission and hormone release, potentially using receptor binding assays.

Main Results:

• AVT is synthesized in the pineal recess and subcommissural organ, stored in the pineal gland, and released into CSF.
• AVT release into CSF occurs during the night, regulated by melatonin.
• AVT activates serotonin neurotransmission, inhibiting hypothalamic hormones and inducing sleep at extremely low concentrations.
• Highly sensitive AVT receptors are located in midbrain raphe nuclei or associated structures.

Conclusions:

• AVT functions as a cerebrospinal fluid (CSF) hormone, primarily acting within the brain.
• AVT is a highly potent regulator of endocrine functions and sleep, mediated by serotonin pathways.
• Its unique mechanism and potency distinguish it from blood-borne analogues like vasopressin and oxytocin.